Synthesis of transcripts using VSW-3 RNA polymerase
The present disclosure provided a RNA polymerase from a psychrophilic bacteriophage VSW-3. The RNA polymerase retains its RNA polymerase activity at low temperature (e.g., as low as 4° C.), is not sensitive to Class II transcription terminator, does not produce 3′ cis extension in the transcripts, and generates transcripts without detectable dsRNA contamination.
1 . A method for performing an in vitro transcription reaction, comprising incubating a RNA polymerase with a DNA molecule and nucleotides for a sufficient time to produce transcripts, wherein the RNA polymerase comprises a polypeptide comprising
1) an amino acid sequence of SEQ ID NO:5, or
2) an amino acid sequence having at least 80% sequence identity to SEQ ID NO:5 and possessing an RNA polymerase activity,
and wherein the DNA molecule comprises a promoter sequence for the RNA polymerase and a DNA sequence to be transcribed.
2 . The method of claim 1 , wherein the RNA polymerase is isolated from a psychrophilic bacteriophage, or is encoded by a gene of a psychrophilic bacteriophage.
3 . The method of claim 2 , wherein the psychrophilic bacteriophage is bacteriophage VSW-3.
4 . The method of claim 1 , wherein the RNA polymerase comprises an amino acid sequence of SEQ ID NO:6.
5 . The method of claim 1 , wherein the incubating is performed at 4-37° C.
6 . The method of claim 1 , wherein the promoter sequence for the RNA polymerase has a nucleotide sequence of SEQ ID NO: 1, 2, 3 or 4.
7 . The method of claim 1 , wherein the incubating is performed in a buffer containing 5 mM DTT.
8 . The method of claim 1 , wherein a class II transcription terminator sequence ATCTGTT does not mediate a transcriptional termination of the transcription reaction.
9 . The method of claim 1 , wherein the DNA sequence to be transcribed comprises a coding sequence for Cas9.
10 . The method of claim 9 , wherein the coding sequence comprises a nucleotide sequence of SEQ ID NO: 9.
11 . The method of claim 1 , wherein the nucleotides comprise pseudoUTP, 5mCTP and/or 5moUTP.
12 . The method of claim 1 , wherein the nucleotides comprise m5CTP, m6ATP, 2′-F-dATP and/or 2′-F-dUTP.
13 . The method of claim 1 , wherein the RNA polymerase comprises an amino acid sequence of SEQ ID NO: 6, and the nucleotides comprises 2′-F-dATP and/or 2′-F-dUTP.